265 related articles for article (PubMed ID: 22386373)
1. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
Hoppe BS; Flampouri S; Su Z; Latif N; Dang NH; Lynch J; Joyce M; Sandler E; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):449-55. PubMed ID: 22386373
[TBL] [Abstract][Full Text] [Related]
2. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
3. Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?
Aznar MC; Maraldo MV; Schut DA; Lundemann M; Brodin NP; Vogelius IR; Berthelsen AK; Specht L; Petersen PM
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):169-74. PubMed ID: 25754634
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
[TBL] [Abstract][Full Text] [Related]
6. Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literature.
Besson N; Pernin V; Zefkili S; Kirova YM
Br J Radiol; 2016; 89(1059):20150409. PubMed ID: 26744079
[TBL] [Abstract][Full Text] [Related]
7. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
[TBL] [Abstract][Full Text] [Related]
8. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
[TBL] [Abstract][Full Text] [Related]
9. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
Hoppe BS; Flampouri S; Zaiden R; Slayton W; Sandler E; Ozdemir S; Dang NH; Lynch JW; Li Z; Morris CG; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1053-1059. PubMed ID: 24928256
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
12. Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease?
Xu N; Ho MW; Li Z; Morris CG; Mendenhall NP
Am J Clin Oncol; 2014 Dec; 37(6):568-74. PubMed ID: 23466577
[TBL] [Abstract][Full Text] [Related]
13. Biological optimization for mediastinal lymphoma radiotherapy - a preliminary study.
Rechner LA; Modiri A; Stick LB; Maraldo MV; Aznar MC; Rice SR; Sawant A; Bentzen SM; Vogelius IR; Specht L
Acta Oncol; 2020 Aug; 59(8):879-887. PubMed ID: 32216586
[No Abstract] [Full Text] [Related]
14. Dosimetric comparison of intensity-modulated radiotherapy plans, with or without anterior myocardial territory and left ventricle as organs at risk, in early-stage left-sided breast cancer patients.
Tan W; Wang X; Qiu D; Liu D; Jia S; Zeng F; Chen Z; Li B; Xu J; Wei L; Hu D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1544-51. PubMed ID: 21470785
[TBL] [Abstract][Full Text] [Related]
15. A dosimetric comparison between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in the treatment of posterior fossa boost in medulloblastoma.
Gupta M; Kant R; Nautiyal V; Bisht J; Raghuvanshi S; Saini M; Kalra BP; Ahmad M
J Cancer Res Ther; 2017; 13(6):1027-1031. PubMed ID: 29237970
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
[TBL] [Abstract][Full Text] [Related]
17. Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study.
Weber DC; Peguret N; Dipasquale G; Cozzi L
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1578-86. PubMed ID: 19596171
[TBL] [Abstract][Full Text] [Related]
18. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.
Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
Ann Oncol; 2013 Aug; 24(8):2113-8. PubMed ID: 23619032
[TBL] [Abstract][Full Text] [Related]
19. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma.
Sachsman S; Hoppe BS; Mendenhall NP; Holtzman A; Li Z; Slayton W; Joyce M; Sandler E; Flampouri S
Leuk Lymphoma; 2015 Jul; 56(7):2019-24. PubMed ID: 25315071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]